✦ LIBER ✦

Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR)

✍ Scribed by Estrada, Anthony A.; Shore, Daniel G.; Blackwood, Elizabeth; Chen, Yung-Hsiang; Deshmukh, Gauri; Ding, Xiao; DiPasquale, Antonio G.; Epler, Jennifer A.; Friedman, Lori S.; Koehler, Michael F. T.; Liu, Lichuan; Malek, Shiva; Nonomiya, Jim; Ortwine, Daniel F.; Pei, Zhonghua; Sideris, Steve; St-Jean, Frederic; Trinh, Lan; Truong, Tom; Lyssikatos, Joseph P.

Book ID: 120008967
Publisher: American Chemical Society
Year: 2013
Tongue: English
Weight: 938 KB
Volume: 56
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm400194n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

52 Discovery of novel fused thiadiazoles

52 Discovery of novel fused thiadiazoles as potent inhibitors of phosphoinositide-3-kinase (PI3K) and/or the mammalian target of rapamycin (mTOR)

✍ J. Pastor; G. Kurz; M.R. Rico Ferreira; D. Soilan; M.A. Ortega; S. Martinez; O. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

ChemInform Abstract: Pyrazolopyrimidines

ChemInform Abstract: Pyrazolopyrimidines as Highly Potent and Selective, ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 1-Substituent.

✍ Kevin J. Curran; Jeroen C. Verheijen; Joshua Kaplan; David J. Richard; Lourdes T 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 19 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Discovery of 4-Morpholino-6-aryl-1 H -py

Discovery of 4-Morpholino-6-aryl-1 H -pyrazolo[3,4- d ]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent

✍ Verheijen, Jeroen C.; Richard, David J.; Curran, Kevin; Kaplan, Joshua; Lefever, 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 161 KB

AZD8055 Is a Potent, Selective, and Oral

AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity

✍ Chresta, C. M.; Davies, B. R.; Hickson, I.; Harding, T.; Cosulich, S.; Critchlow 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 932 KB

320 Identification of potent, selective,

320 Identification of potent, selective, soluble and permeable small molecule PI3 kinase inhibitors for the treatment of cancer

✍ K. Ahmadi; W. Alderton; I. Chuckowree; P. Depledge; A. Folkes; G. Pergl-Wilson; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Combining the receptor tyrosine kinase i

Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells

✍ Eva Juengel; Johanna Engler; Iyad Natsheh; Jon Jones; Ausra Mickuckyte; Lukasz H 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 924 KB